COST-EFFECTIVENESS ANALYSIS OF PALIVIZUMAB WITH RISK FACTORS FOR RESPIRATORY SYNCYTIAL VIRUS PREVENTION

被引：0
|
作者：
Lee, M. Y. [1 ]
Lee, E. K. [1 ]
机构：
[1] Sungkyunkwan Univ, Suwon, Gyeonggi Do, South Korea
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.1139
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A398 / A398
页数：1
相关论文
共 50 条
  • [1] A review of cost-effectiveness of palivizumab for respiratory syncytial virus
    Hussman, Julia M.
    Li, Abby
    Paes, Bosco
    Lanctot, Krista L.
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (05) : 553 - 567
  • [2] Cost-effectiveness of respiratory syncytial virus prophylaxis with palivizumab
    Reeve, Carole A.
    Whitehall, John S.
    Buettner, Petra G.
    Norton, Robert
    Reeve, David M.
    Francis, Fleur
    [J]. JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2006, 42 (05) : 253 - 258
  • [3] Cost-effectiveness of respiratory syncytial virus prophylaxis with palivizumab
    Mahadevia, Parthiv J.
    Malinoski, Frank J.
    [J]. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2007, 161 (05): : 519 - 520
  • [4] The Cost-Effectiveness of Palivizumab in the Prevention of Respiratory Syncytial Virus Bronchiolitis: A Systematic Review
    Blanken, Maarten
    Bont, Louis
    Rovers, Maroeska
    [J]. CURRENT RESPIRATORY MEDICINE REVIEWS, 2011, 7 (03) : 203 - 212
  • [5] Palivizumab for respiratory syncytial virus prophylaxis in high-risk infants: A cost-effectiveness analysis
    Lolfand, JH
    Touch, SM
    O'Connor, JP
    Chatterton, ML
    Moxey, ED
    Paddock, LE
    Nash, DB
    Desai, SA
    [J]. CLINICAL THERAPEUTICS, 2000, 22 (11) : 1357 - 1369
  • [6] Cost-effectiveness of Palivizumab for Respiratory Syncytial Virus: A Systematic Review
    Mac, Stephen
    Sumner, Amanda
    Duchesne-Belanger, Samuel
    Stirling, Robert
    Tunis, Matthew
    Sander, Beate
    [J]. PEDIATRICS, 2019, 143 (05)
  • [7] Cost-effectiveness of respiratory syncytial virus prophylaxis with palivizumab - Reply
    Sorbero, Melony E. S.
    ElHassan, Nahed O.
    Hall, Caroline B.
    Stevens, Timothy P.
    Dick, Andrew W.
    [J]. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2007, 161 (05): : 520 - 520
  • [8] Cost-effectiveness analysis of palivizumab for respiratory syncytial virus infection in high-risk infants in Japan
    Ikeda, S.
    Kobayashi, M.
    [J]. VALUE IN HEALTH, 2007, 10 (03) : A170 - A170
  • [9] Cost-effectiveness analysis of palivizumab as respiratory syncytial virus prophylaxis in preterm infants in Sweden
    Neovius, Kristian
    Buesch, Katharina
    Sandstrom, Kristina
    Neovius, Martin
    [J]. ACTA PAEDIATRICA, 2011, 100 (10) : 1306 - 1314
  • [10] COST-EFFECTIVENESS ANALYSIS OF PALIVIZUMAB IN THE PREVENTION OF RESPIRATORY SYNCYTIAL VIRUS INFECTION IN KOREAN CHILDREN WITH CONGENITAL HEART DISEASE
    Kang, H. Y.
    Kim, H. S.
    Choi, J. Y.
    Kim, Y. H.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A424 - A424
12345